Consequently, LINC00240, RBMS3-AS3, and ALG9-IT1 May represent new functional lncRNAs that mitigate liver fibrosis in NAFLD by influencing the ECM via the ceRNA network [66]. This evidence concerns the gene ALG9 and metabolic dysfunction-associated steatotic liver disease.